{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:49:06Z","timestamp":1787755746234,"version":"build-2784847793"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Abdominal aortic aneurysm (AAA) is a degenerative disease characterized by aortic dilation and rupture leading to sudden death. Currently, no non-surgical treatments are available and novel therapeutic targets are needed to prevent AAA. We investigated whether increasing plasma levels of adiponectin (APN), a pleiotropic adipokine, provides therapeutic benefit to prevent AngII-induced advanced AAA in a well-established preclinical model. In the AngII-infused hyperlipidemic low-density lipoprotein receptor-deficient mouse (LDLR\n                    <jats:sup>\u2212\/\u2212<\/jats:sup>\n                    ) model, we induced plasma APN levels using a recombinant adenovirus expressing mouse APN (AdAPN) and as control, adenovirus expressing green florescent protein (AdGFP). APN expression produced sustained and significant elevation of total and high-molecular weight APN levels and enhanced APN localization in the artery wall. AngII infusion for 8 weeks induced advanced AAA development in AdGFP mice. Remarkably, APN inhibited the AAA development in AdAPN mice by suppressing aortic inflammatory cell infiltration, medial degeneration and elastin fragmentation. APN inhibited the angiotensin type-1 receptor (AT1R), inflammatory cytokine and mast cell protease expression and induced lysyl oxidase (LOX) in the aortic wall, improved systemic cytokine profile and attenuated adipose inflammation. These studies strongly support APN therapeutic actions through multiple mechanisms inhibiting AngII-induced AAA and increasing plasma APN levels as a strategy to prevent advanced AAA.\n                  <\/jats:p>","DOI":"10.1038\/srep31414","type":"journal-article","created":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T05:07:53Z","timestamp":1474607273000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Elevated Adiponectin Levels Suppress Perivascular and Aortic Inflammation and Prevent AngII-induced Advanced Abdominal Aortic Aneurysms"],"prefix":"10.1038","volume":"6","author":[{"given":"Dick","family":"W\u00e5gs\u00e4ter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emina","family":"Vorkapic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M. W.","family":"van Stijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldons J.","family":"Lusis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra K.","family":"Tangirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,9,23]]},"reference":[{"key":"BFsrep31414_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrcardio.2010.180","volume":"8","author":"IM Nordon","year":"2011","unstructured":"Nordon, I. M., Hinchliffe, R. J., Loftus, I. M. & Thompson, M. M. Pathophysiology and epidemiology of abdominal aortic aneurysms. Nature reviews. Cardiology 8, 92\u2013102, 10.1038\/nrcardio.2010.180 (2011).","journal-title":"Nature reviews. Cardiology"},{"key":"BFsrep31414_CR2","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/01.ATV.0000245819.32762.cb","volume":"26","author":"J Golledge","year":"2006","unstructured":"Golledge, J., Muller, J., Daugherty, A. & Norman, P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arteriosclerosis, thrombosis and vascular biology 26, 2605\u20132613, 10.1161\/01.ATV.0000245819.32762.cb (2006).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR3","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1161\/01.ATV.0000214999.12921.4f","volume":"26","author":"K Shimizu","year":"2006","unstructured":"Shimizu, K., Mitchell, R. N. & Libby, P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arteriosclerosis, thrombosis and vascular biology 26, 987\u2013994, 10.1161\/01.ATV.0000214999.12921.4f (2006).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR4","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/heartjnl-2014-305648","volume":"100","author":"FM Davis","year":"2014","unstructured":"Davis, F. M., Rateri, D. L. & Daugherty, A. Mechanisms of aortic aneurysm formation: translating preclinical studies into clinical therapies. Heart 100, 1498\u20131505, 10.1136\/heartjnl-2014-305648 (2014).","journal-title":"Heart"},{"key":"BFsrep31414_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0741-5214(90)90163-5","volume":"12","author":"MD Tilson","year":"1990","unstructured":"Tilson, M. D. Atherosclerosis and aneurysm disease. Journal of vascular surgery 12, 371\u2013372 (1990).","journal-title":"Journal of vascular surgery"},{"key":"BFsrep31414_CR6","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1161\/ATVBAHA.110.203588","volume":"30","author":"SH Johnsen","year":"2010","unstructured":"Johnsen, S. H., Forsdahl, S. H., Singh, K. & Jacobsen, B. K. Atherosclerosis in abdominal aortic aneurysms: a causal event or a process running in parallel? The Tromso study. Arteriosclerosis, thrombosis and vascular biology 30, 1263\u20131268, 10.1161\/ATVBAHA.110.203588 (2010).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil, G. S. Inflammation and metabolic disorders. Nature 444, 860\u2013867, 10.1038\/nature05485 (2006).","journal-title":"Nature"},{"key":"BFsrep31414_CR8","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2014.05.923","volume":"235","author":"S Yoshida","year":"2014","unstructured":"Yoshida, S., Fuster, J. J. & Walsh, K. Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. Atherosclerosis 235, 339\u2013346, 10.1016\/j.atherosclerosis.2014.05.923 (2014).","journal-title":"Atherosclerosis"},{"key":"BFsrep31414_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/ATVBAHA.112.300543","volume":"33","author":"M Tao","year":"2013","unstructured":"Tao, M. et al. Locally applied leptin induces regional aortic wall degeneration preceding aneurysm formation in apolipoprotein E-deficient mice. Arteriosclerosis, thrombosis and vascular biology 33, 311\u2013320, 10.1161\/ATVBAHA.112.300543 (2013).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR10","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1161\/CIRCULATIONAHA.107.717926","volume":"116","author":"J Golledge","year":"2007","unstructured":"Golledge, J., Clancy, P., Jamrozik, K. & Norman, P. E. Obesity, adipokines and abdominal aortic aneurysm: Health in Men study. Circulation 116, 2275\u20132279, 10.1161\/CIRCULATIONAHA.107.717926 (2007).","journal-title":"Circulation"},{"key":"BFsrep31414_CR11","doi-asserted-by":"publisher","first-page":"e86404","DOI":"10.1371\/journal.pone.0086404","volume":"9","author":"CM van Stijn","year":"2014","unstructured":"van Stijn, C. M., Kim, J., Barish, G. D., Tietge, U. J. & Tangirala, R. K. Adiponectin Expression Protects against Angiotensin II-Mediated Inflammation and Accelerated Atherosclerosis. PloS one 9, e86404, 10.1371\/journal.pone.0086404 (2014).","journal-title":"PloS one"},{"key":"BFsrep31414_CR12","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.RES.0000163635.62927.34","volume":"96","author":"AH Berg","year":"2005","unstructured":"Berg, A. H. & Scherer, P. E. Adipose tissue, inflammation and cardiovascular disease. Circulation research 96, 939\u2013949, 10.1161\/01.RES.0000163635.62927.34 (2005).","journal-title":"Circulation research"},{"key":"BFsrep31414_CR13","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1365-2796.2010.02247.x","volume":"268","author":"J Persson","year":"2010","unstructured":"Persson, J. et al. Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. Journal of internal medicine 268, 194\u2013205, 10.1111\/j.1365-2796.2010.02247.x (2010).","journal-title":"Journal of internal medicine"},{"key":"BFsrep31414_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nm.2277","volume":"17","author":"WL Holland","year":"2011","unstructured":"Holland, W. L. et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nature medicine 17, 55\u201363, 10.1038\/nm.2277 (2011).","journal-title":"Nature medicine"},{"key":"BFsrep31414_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/nm1557","volume":"13","author":"T Yamauchi","year":"2007","unstructured":"Yamauchi, T. et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature medicine 13, 332\u2013339, 10.1038\/nm1557 (2007).","journal-title":"Nature medicine"},{"key":"BFsrep31414_CR16","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1096\/fj.14-253831","volume":"29","author":"CM van Stijn","year":"2015","unstructured":"van Stijn, C. M., Kim, J., Lusis, A. J., Barish, G. D. & Tangirala, R. K. Macrophage polarization phenotype regulates adiponectin receptor expression and adiponectin anti-inflammatory response. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 29, 636\u2013649, 10.1096\/fj.14-253831 (2015).","journal-title":"FASEB journal: official publication of the Federation of American Societies for Experimental Biology"},{"key":"BFsrep31414_CR17","doi-asserted-by":"publisher","first-page":"12152","DOI":"10.1074\/jbc.M311113200","volume":"279","author":"UB Pajvani","year":"2004","unstructured":"Pajvani, U. B. et al. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. The Journal of biological chemistry 279, 12152\u201312162, 10.1074\/jbc.M311113200 (2004).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep31414_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1111\/j.1749-6632.1999.tb07789.x","volume":"892","author":"A Daugherty","year":"1999","unstructured":"Daugherty, A. & Cassis, L. Chronic angiotensin II infusion promotes atherogenesis in low density lipoprotein receptor \u2212\/\u2212 mice. Annals of the New York Academy of Sciences 892, 108\u2013118 (1999).","journal-title":"Annals of the New York Academy of Sciences"},{"key":"BFsrep31414_CR19","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/00019501-199710000-00005","volume":"8","author":"RW Thompson","year":"1997","unstructured":"Thompson, R. W., Liao, S. & Curci, J. A. Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms. Coronary artery disease 8, 623\u2013631 (1997).","journal-title":"Coronary artery disease"},{"key":"BFsrep31414_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1172\/JCI22309","volume":"114","author":"JA Curci","year":"2004","unstructured":"Curci, J. A. & Thompson, R. W. Adaptive cellular immunity in aortic aneurysms: cause, consequence, or context? The Journal of clinical investigation 114, 168\u2013171, 10.1172\/JCI22309 (2004).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep31414_CR21","first-page":"993","volume":"150","author":"A Lopez-Candales","year":"1997","unstructured":"Lopez-Candales, A. et al. Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms. The American journal of pathology 150, 993\u20131007 (1997).","journal-title":"The American journal of pathology"},{"key":"BFsrep31414_CR22","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1161\/01.ATV.0000254680.71485.92","volume":"27","author":"LA Cassis","year":"2007","unstructured":"Cassis, L. A., Rateri, D. L., Lu, H. & Daugherty, A. Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms. Arteriosclerosis, thrombosis and vascular biology 27, 380\u2013386, 10.1161\/01.ATV.0000254680.71485.92 (2007).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR23","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/ATVBAHA.110.213157","volume":"31","author":"J Swedenborg","year":"2011","unstructured":"Swedenborg, J., Mayranpaa, M. I. & Kovanen, P. T. Mast cells: important players in the orchestrated pathogenesis of abdominal aortic aneurysms. Arteriosclerosis, thrombosis and vascular biology 31, 734\u2013740, 10.1161\/ATVBAHA.110.213157 (2011).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR24","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1161\/01.ATV.0000166601.49954.21","volume":"25","author":"M Kazi","year":"2005","unstructured":"Kazi, M. et al. Difference in matrix-degrading protease expression and activity between thrombus-free and thrombus-covered wall of abdominal aortic aneurysm. Arteriosclerosis, thrombosis and vascular biology 25, 1341\u20131346, 10.1161\/01.ATV.0000166601.49954.21 (2005).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR25","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/CIRCULATIONAHA.109.849679","volume":"120","author":"J Sun","year":"2009","unstructured":"Sun, J. et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 120, 973\u2013982, 10.1161\/CIRCULATIONAHA.109.849679 (2009).","journal-title":"Circulation"},{"key":"BFsrep31414_CR26","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1172\/JCI8931","volume":"105","author":"R Pyo","year":"2000","unstructured":"Pyo, R. et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. The Journal of clinical investigation 105, 1641\u20131649, 10.1172\/JCI8931 (2000).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep31414_CR27","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1161\/01.CIR.0000038109.84500.1E","volume":"106","author":"JM Maki","year":"2002","unstructured":"Maki, J. M. et al. Inactivation of the lysyl oxidase gene Lox leads to aortic aneurysms, cardiovascular dysfunction and perinatal death in mice. Circulation 106, 2503\u20132509 (2002).","journal-title":"Circulation"},{"key":"BFsrep31414_CR28","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0021-9258(19)75188-6","volume":"252","author":"DW Rowe","year":"1977","unstructured":"Rowe, D. W., McGoodwin, E. B., Martin, G. R. & Grahn, D. Decreased lysyl oxidase activity in the aneurysm-prone, mottled mouse. The Journal of biological chemistry 252, 939\u2013942 (1977).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep31414_CR29","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1161\/01.ATV.17.11.2843","volume":"17","author":"J Juvonen","year":"1997","unstructured":"Juvonen, J. et al. Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arteriosclerosis, thrombosis and vascular biology 17, 2843\u20132847 (1997).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3233\/DMA-2009-0629","volume":"26","author":"AL Golledge","year":"2009","unstructured":"Golledge, A. L., Walker, P., Norman, P. E. & Golledge, J. A systematic review of studies examining inflammation associated cytokines in human abdominal aortic aneurysm samples. Disease markers 26, 181\u2013188, 10.3233\/DMA-2009-0629 (2009).","journal-title":"Disease markers"},{"key":"BFsrep31414_CR31","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/ATVBAHA.109.192658","volume":"29","author":"SB Police","year":"2009","unstructured":"Police, S. B., Thatcher, S. E., Charnigo, R., Daugherty, A. & Cassis, L. A. Obesity promotes inflammation in periaortic adipose tissue and angiotensin II-induced abdominal aortic aneurysm formation. Arteriosclerosis, thrombosis and vascular biology 29, 1458\u20131464, 10.1161\/ATVBAHA.109.192658 (2009).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR32","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.ajpath.2011.05.049","volume":"179","author":"DL Rateri","year":"2011","unstructured":"Rateri, D. L. et al. Prolonged infusion of angiotensin II in apoE(\u2212\/\u2212) mice promotes macrophage recruitment with continued expansion of abdominal aortic aneurysm. The American journal of pathology 179, 1542\u20131548, 10.1016\/j.ajpath.2011.05.049 (2011).","journal-title":"The American journal of pathology"},{"key":"BFsrep31414_CR33","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1172\/JCI7818","volume":"105","author":"A Daugherty","year":"2000","unstructured":"Daugherty, A., Manning, M. W. & Cassis, L. A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. The Journal of clinical investigation 105, 1605\u20131612, 10.1172\/JCI7818 (2000).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep31414_CR34","first-page":"703","volume":"22","author":"Y Fujiwara","year":"2008","unstructured":"Fujiwara, Y. et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. International journal of molecular medicine 22, 703\u2013708 (2008).","journal-title":"International journal of molecular medicine"},{"key":"BFsrep31414_CR35","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1097\/HJH.0b013e328313e547","volume":"26","author":"E Kaschina","year":"2008","unstructured":"Kaschina, E. et al. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. Journal of hypertension 26, 2361\u20132373, 10.1097\/HJH.0b013e328313e547 (2008).","journal-title":"Journal of hypertension"},{"key":"BFsrep31414_CR36","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1161\/ATVBAHA.107.155564","volume":"28","author":"GT Jones","year":"2008","unstructured":"Jones, G. T. et al. Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arteriosclerosis, thrombosis and vascular biology 28, 764\u2013770, 10.1161\/ATVBAHA.107.155564 (2008).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR37","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1161\/01.ATV.15.8.1145","volume":"15","author":"T Freestone","year":"1995","unstructured":"Freestone, T. et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arteriosclerosis, thrombosis and vascular biology 15, 1145\u20131151 (1995).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR38","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/nm1335","volume":"11","author":"K Yoshimura","year":"2005","unstructured":"Yoshimura, K. et al. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nature medicine 11, 1330\u20131338, 10.1038\/nm1335 (2005).","journal-title":"Nature medicine"},{"key":"BFsrep31414_CR39","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.atherosclerosis.2009.07.036","volume":"208","author":"M Onoda","year":"2010","unstructured":"Onoda, M. et al. Lysyl oxidase resolves inflammation by reducing monocyte chemoattractant protein-1 in abdominal aortic aneurysm. Atherosclerosis 208, 366\u2013369, 10.1016\/j.atherosclerosis.2009.07.036 (2010).","journal-title":"Atherosclerosis"},{"key":"BFsrep31414_CR40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1161\/01.CIR.95.1.205","volume":"95","author":"JB Knox","year":"1997","unstructured":"Knox, J. B., Sukhova, G. K., Whittemore, A. D. & Libby, P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 95, 205\u2013212 (1997).","journal-title":"Circulation"},{"key":"BFsrep31414_CR41","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1161\/01.ATV.0000160548.78317.29","volume":"25","author":"SJ Zieman","year":"2005","unstructured":"Zieman, S. J., Melenovsky, V. & Kass, D. A. Mechanisms, pathophysiology and therapy of arterial stiffness. Arteriosclerosis, thrombosis and vascular biology 25, 932\u2013943, 10.1161\/01.ATV.0000160548.78317.29 (2005).","journal-title":"Arteriosclerosis, thrombosis and vascular biology"},{"key":"BFsrep31414_CR42","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1016\/j.yexcr.2005.12.033","volume":"312","author":"MJ Leskinen","year":"2006","unstructured":"Leskinen, M. J. et al. Mast cell chymase induces smooth muscle cell apoptosis by disrupting NF-kappaB-mediated survival signaling. Experimental cell research 312, 1289\u20131298, 10.1016\/j.yexcr.2005.12.033 (2006).","journal-title":"Experimental cell research"},{"key":"BFsrep31414_CR43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jvs.2009.03.055","volume":"50","author":"MI Mayranpaa","year":"2009","unstructured":"Mayranpaa, M. I. et al. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. Journal of vascular surgery 50, 388\u2013395; discussion 395-386, 10.1016\/j.jvs.2009.03.055 (2009).","journal-title":"Journal of vascular surgery"},{"key":"BFsrep31414_CR44","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1582-4934.2007.00052.x","volume":"11","author":"KA Lindstedt","year":"2007","unstructured":"Lindstedt, K. A., Mayranpaa, M. I. & Kovanen, P. T. Mast cells in vulnerable atherosclerotic plaques\u2013a view to a kill. Journal of cellular and molecular medicine 11, 739\u2013758, 10.1111\/j.1582-4934.2007.00052.x (2007).","journal-title":"Journal of cellular and molecular medicine"},{"key":"BFsrep31414_CR45","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tcm.2012.07.012","volume":"22","author":"Y Wang","year":"2012","unstructured":"Wang, Y. & Shi, G. P. Mast cell chymase and tryptase in abdominal aortic aneurysm formation. Trends in cardiovascular medicine 22, 150\u2013155, 10.1016\/j.tcm.2012.07.012 (2012).","journal-title":"Trends in cardiovascular medicine"},{"key":"BFsrep31414_CR46","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0002-9440(10)64206-X","volume":"161","author":"U Schonbeck","year":"2002","unstructured":"Schonbeck, U., Sukhova, G. K., Gerdes, N. & Libby, P. T(H)2 predominant immune responses prevail in human abdominal aortic aneurysm. The American journal of pathology 161, 499\u2013506, 10.1016\/S0002-9440(10)64206-X (2002).","journal-title":"The American journal of pathology"},{"key":"BFsrep31414_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","volume":"145","author":"J Frostegard","year":"1999","unstructured":"Frostegard, J. et al. Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145, 33\u201343 (1999).","journal-title":"Atherosclerosis"},{"key":"BFsrep31414_CR48","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.4049\/jimmunol.172.4.2607","volume":"172","author":"W Xiong","year":"2004","unstructured":"Xiong, W., Zhao, Y., Prall, A., Greiner, T. C. & Baxter, B. T. Key roles of CD4+\u2009T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. Journal of immunology 172, 2607\u20132612 (2004).","journal-title":"Journal of immunology"},{"key":"BFsrep31414_CR49","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nature reviews. Immunology 11, 723\u2013737, 10.1038\/nri3073 (2011).","journal-title":"Nature reviews. Immunology"},{"key":"BFsrep31414_CR50","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1016\/j.clinthera.2006.10.012","volume":"28","author":"S Watanabe","year":"2006","unstructured":"Watanabe, S. et al. The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension. Clinical therapeutics 28, 1677\u20131685, 10.1016\/j.clinthera.2006.10.012 (2006).","journal-title":"Clinical therapeutics"},{"key":"BFsrep31414_CR51","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1073\/pnas.0708647105","volume":"105","author":"Y Takata","year":"2008","unstructured":"Takata, Y. et al. PPARdelta-mediated antiinflammatory mechanisms inhibit angiotensin II-accelerated atherosclerosis. Proc Natl Acad Sci USA 105, 4277\u20134282, 10.1073\/pnas.0708647105 (2008).","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31414","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31414.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:21:30Z","timestamp":1672845690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,23]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,11,14]]}},"alternative-id":["BFsrep31414"],"URL":"https:\/\/doi.org\/10.1038\/srep31414","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,23]]},"assertion":[{"value":"8 April 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31414"}}